Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria

Kate M Mitchell; Aurélia Lépine; Fern Terris-Prestholt; Kwasi Torpey; Hadiza Khamofu; Morenike O Folayan; Jonah Musa; James Anenih; Atiene S Sagay; Emmanuel Alhassan; John Idoko; Peter Vickerman

doi:10.1097/QAD.0000000000000798

Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria

Kate M Mitchell
, Aurélia Lépine
, Fern Terris-Prestholt
, Kwasi Torpey
, Hadiza Khamofu
, Morenike O Folayan
, Jonah Musa
, James Anenih
, Atiene S Sagay
, Emmanuel Alhassan
, John Idoko
, Peter Vickerman

Research output: Contribution to journal › Article (Academic Journal) › peer-review

38 Citations (Scopus)

469 Downloads (Pure)

Abstract

OBJECTIVE: To estimate the impact and cost-effectiveness of treatment as prevention (TasP), pre-exposure prophylaxis (PrEP) and condom promotion for serodiscordant couples in Nigeria.

DESIGN: Mathematical and cost modelling.

METHODS: A deterministic model of HIV-1 transmission within a cohort of serodiscordant couples and to/from external partners was parameterized using data from Nigeria and other African settings. The impact and cost-effectiveness were estimated for condom promotion, PrEP and/or TasP, compared with a baseline where antiretroviral therapy (ART) was offered according to 2010 national guidelines (CD4 <350 cells/μl) to all HIV-positive partners. The impact was additionally compared with a baseline of current ART coverage (35% of those with CD4 <350 cells/μl). Full costs (in US $2012) of programme introduction and implementation were estimated from a provider perspective.

RESULTS: Substantial benefits came from scaling up ART to all HIV-positive partners according to 2010 national guidelines, with additional smaller benefits of providing TasP, PrEP or condom promotion. Compared with a baseline of offering ART to all HIV-positive partners at the 2010 national guidelines, condom promotion was the most cost-effective strategy [US $1206/disability-adjusted-life-year (DALY)], the next most cost-effective intervention was to additionally give TasP to HIV-positive partners (incremental cost-effectiveness ratio US $1607/DALY), followed by additionally giving PrEP to HIV-negative partners until their HIV-positive partners initiate ART (US $7870/DALY). When impact was measured in terms of infections averted, PrEP with condom promotion prevented double the number of infections as condom promotion alone.

CONCLUSIONS: The first priority intervention for serodiscordant couples in Nigeria should be scaled up ART access for HIV-positive partners. Subsequent incremental benefits are greatest with condom promotion and TasP, followed by PrEP.

Original language	English
Pages (from-to)	2035-2044
Number of pages	10
Journal	AIDS
Volume	29
Issue number	15
DOIs	https://doi.org/10.1097/QAD.0000000000000798
Publication status	Published - 24 Sept 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Groups and Themes

GEM-B

Keywords

Adolescent
Adult
Anti-Retroviral Agents
Chemoprevention
Cohort Studies
Condoms
Cost-Benefit Analysis
Disease Transmission, Infectious
Female
HIV Infections
HIV Seronegativity
HIV Seropositivity
Humans
Male
Middle Aged
Models, Theoretical
Nigeria
Pre-Exposure Prophylaxis
Sexual Partners
Young Adult
Journal Article
Research Support, Non-U.S. Gov't

Access to Document

10.1097/QAD.0000000000000798

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via LWW at http://journals.lww.com/aidsonline/pages/articleviewer.aspx?year=2015&issue=09240&article=00016&type=abstract. Please refer to any applicable terms of use of the publisher.
Final published version, 237 KBLicence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

@article{1694862205034184b6b43acb11f883cd,

title = "Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria",

abstract = "OBJECTIVE: To estimate the impact and cost-effectiveness of treatment as prevention (TasP), pre-exposure prophylaxis (PrEP) and condom promotion for serodiscordant couples in Nigeria.DESIGN: Mathematical and cost modelling.METHODS: A deterministic model of HIV-1 transmission within a cohort of serodiscordant couples and to/from external partners was parameterized using data from Nigeria and other African settings. The impact and cost-effectiveness were estimated for condom promotion, PrEP and/or TasP, compared with a baseline where antiretroviral therapy (ART) was offered according to 2010 national guidelines (CD4 <350 cells/μl) to all HIV-positive partners. The impact was additionally compared with a baseline of current ART coverage (35\% of those with CD4 <350 cells/μl). Full costs (in US \$2012) of programme introduction and implementation were estimated from a provider perspective.RESULTS: Substantial benefits came from scaling up ART to all HIV-positive partners according to 2010 national guidelines, with additional smaller benefits of providing TasP, PrEP or condom promotion. Compared with a baseline of offering ART to all HIV-positive partners at the 2010 national guidelines, condom promotion was the most cost-effective strategy [US \$1206/disability-adjusted-life-year (DALY)], the next most cost-effective intervention was to additionally give TasP to HIV-positive partners (incremental cost-effectiveness ratio US \$1607/DALY), followed by additionally giving PrEP to HIV-negative partners until their HIV-positive partners initiate ART (US \$7870/DALY). When impact was measured in terms of infections averted, PrEP with condom promotion prevented double the number of infections as condom promotion alone.CONCLUSIONS: The first priority intervention for serodiscordant couples in Nigeria should be scaled up ART access for HIV-positive partners. Subsequent incremental benefits are greatest with condom promotion and TasP, followed by PrEP.",

keywords = "Adolescent, Adult, Anti-Retroviral Agents, Chemoprevention, Cohort Studies, Condoms, Cost-Benefit Analysis, Disease Transmission, Infectious, Female, HIV Infections, HIV Seronegativity, HIV Seropositivity, Humans, Male, Middle Aged, Models, Theoretical, Nigeria, Pre-Exposure Prophylaxis, Sexual Partners, Young Adult, Journal Article, Research Support, Non-U.S. Gov't",

author = "Mitchell, \{Kate M\} and Aur{\'e}lia L{\'e}pine and Fern Terris-Prestholt and Kwasi Torpey and Hadiza Khamofu and Folayan, \{Morenike O\} and Jonah Musa and James Anenih and Sagay, \{Atiene S\} and Emmanuel Alhassan and John Idoko and Peter Vickerman",

year = "2015",

month = sep,

day = "24",

doi = "10.1097/QAD.0000000000000798",

language = "English",

volume = "29",

pages = "2035--2044",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "15",

}

TY - JOUR

T1 - Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria

AU - Mitchell, Kate M

AU - Lépine, Aurélia

AU - Terris-Prestholt, Fern

AU - Torpey, Kwasi

AU - Khamofu, Hadiza

AU - Folayan, Morenike O

AU - Musa, Jonah

AU - Anenih, James

AU - Sagay, Atiene S

AU - Alhassan, Emmanuel

AU - Idoko, John

AU - Vickerman, Peter

PY - 2015/9/24

Y1 - 2015/9/24

N2 - OBJECTIVE: To estimate the impact and cost-effectiveness of treatment as prevention (TasP), pre-exposure prophylaxis (PrEP) and condom promotion for serodiscordant couples in Nigeria.DESIGN: Mathematical and cost modelling.METHODS: A deterministic model of HIV-1 transmission within a cohort of serodiscordant couples and to/from external partners was parameterized using data from Nigeria and other African settings. The impact and cost-effectiveness were estimated for condom promotion, PrEP and/or TasP, compared with a baseline where antiretroviral therapy (ART) was offered according to 2010 national guidelines (CD4 <350 cells/μl) to all HIV-positive partners. The impact was additionally compared with a baseline of current ART coverage (35% of those with CD4 <350 cells/μl). Full costs (in US $2012) of programme introduction and implementation were estimated from a provider perspective.RESULTS: Substantial benefits came from scaling up ART to all HIV-positive partners according to 2010 national guidelines, with additional smaller benefits of providing TasP, PrEP or condom promotion. Compared with a baseline of offering ART to all HIV-positive partners at the 2010 national guidelines, condom promotion was the most cost-effective strategy [US $1206/disability-adjusted-life-year (DALY)], the next most cost-effective intervention was to additionally give TasP to HIV-positive partners (incremental cost-effectiveness ratio US $1607/DALY), followed by additionally giving PrEP to HIV-negative partners until their HIV-positive partners initiate ART (US $7870/DALY). When impact was measured in terms of infections averted, PrEP with condom promotion prevented double the number of infections as condom promotion alone.CONCLUSIONS: The first priority intervention for serodiscordant couples in Nigeria should be scaled up ART access for HIV-positive partners. Subsequent incremental benefits are greatest with condom promotion and TasP, followed by PrEP.

AB - OBJECTIVE: To estimate the impact and cost-effectiveness of treatment as prevention (TasP), pre-exposure prophylaxis (PrEP) and condom promotion for serodiscordant couples in Nigeria.DESIGN: Mathematical and cost modelling.METHODS: A deterministic model of HIV-1 transmission within a cohort of serodiscordant couples and to/from external partners was parameterized using data from Nigeria and other African settings. The impact and cost-effectiveness were estimated for condom promotion, PrEP and/or TasP, compared with a baseline where antiretroviral therapy (ART) was offered according to 2010 national guidelines (CD4 <350 cells/μl) to all HIV-positive partners. The impact was additionally compared with a baseline of current ART coverage (35% of those with CD4 <350 cells/μl). Full costs (in US $2012) of programme introduction and implementation were estimated from a provider perspective.RESULTS: Substantial benefits came from scaling up ART to all HIV-positive partners according to 2010 national guidelines, with additional smaller benefits of providing TasP, PrEP or condom promotion. Compared with a baseline of offering ART to all HIV-positive partners at the 2010 national guidelines, condom promotion was the most cost-effective strategy [US $1206/disability-adjusted-life-year (DALY)], the next most cost-effective intervention was to additionally give TasP to HIV-positive partners (incremental cost-effectiveness ratio US $1607/DALY), followed by additionally giving PrEP to HIV-negative partners until their HIV-positive partners initiate ART (US $7870/DALY). When impact was measured in terms of infections averted, PrEP with condom promotion prevented double the number of infections as condom promotion alone.CONCLUSIONS: The first priority intervention for serodiscordant couples in Nigeria should be scaled up ART access for HIV-positive partners. Subsequent incremental benefits are greatest with condom promotion and TasP, followed by PrEP.

KW - Adolescent

KW - Adult

KW - Anti-Retroviral Agents

KW - Chemoprevention

KW - Cohort Studies

KW - Condoms

KW - Cost-Benefit Analysis

KW - Disease Transmission, Infectious

KW - Female

KW - HIV Infections

KW - HIV Seronegativity

KW - HIV Seropositivity

KW - Humans

KW - Male

KW - Middle Aged

KW - Models, Theoretical

KW - Nigeria

KW - Pre-Exposure Prophylaxis

KW - Sexual Partners

KW - Young Adult

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568890/

U2 - 10.1097/QAD.0000000000000798

DO - 10.1097/QAD.0000000000000798

M3 - Article (Academic Journal)

C2 - 26355574

SN - 0269-9370

VL - 29

SP - 2035

EP - 2044

JO - AIDS

JF - AIDS

IS - 15

ER -

Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria

Abstract

UN SDGs

Research Groups and Themes

Keywords

Access to Document

Handle.net

Other files and links

Embargoed Document

Fingerprint

Cite this